Kyongbo Pharmaceutical, a subsidiary of Chong Kun Dang, said on the 15th that it recently built an antibody-drug conjugate (ADC) research center in Yongin to produce preclinical research samples and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results